UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050868
Receipt number R000057973
Scientific Title Creation of a Japanese version of the Freezing of gait questionnaire and verification of its reliability and validity
Date of disclosure of the study information 2023/04/17
Last modified on 2023/04/17 14:45:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Creation of a Japanese version of the Freezing of gait questionnaire and verification of its reliability and validity

Acronym

Creation of a Japanese version of the Freezing of gait questionnaire and verification of its reliability and validity

Scientific Title

Creation of a Japanese version of the Freezing of gait questionnaire and verification of its reliability and validity

Scientific Title:Acronym

Creation of a Japanese version of the Freezing of gait questionnaire and verification of its reliability and validity

Region

Japan


Condition

Condition

Parkinson's disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To develop a Japanese version of the FOGQ and verify its validity and reliability

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Freezing of Gait questionnaire

Key secondary outcomes

Fall Efficacy Scale
2-Step Test
Unified Parkinson's Disease Rating Scale


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Parkinson's disease patient able to walk with a walking aid and perform a two-step test

Key exclusion criteria

Those who have difficulty understanding the research

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kicyoru
Middle name
Last name Kim

Organization

Medical Corporation Kayoukai Kawaguchi Neurosurgery Rehabilitation Clinic

Division name

Department of Rehabilitation

Zip code

5730086

Address

9-25-202 Kourien-cho, Hirakata City, Osaka, Japan

TEL

0728351010

Email

kawaguchi.ns.reha@gmail.com


Public contact

Name of contact person

1st name Shinya
Middle name
Last name Iki

Organization

Medical Corporation Kayoukai Kawaguchi Neurosurgery Rehabilitation Clinic

Division name

Department of Rehabilitation

Zip code

5730086

Address

9-25-202 Kourien-cho, Hirakata City, Osaka, Japan

TEL

0728351010

Homepage URL


Email

kawaguchi.ns.reha@gmail.com


Sponsor or person

Institute

Medical Corporation Kayoukai Kawaguchi Neurosurgery Rehabilitation Clinic

Institute

Department

Personal name



Funding Source

Organization

Non

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation Kayoukai Kawaguchi Neurosurgery Rehabilitation Clinic

Address

9-25-202 Kourien-cho, Hirakata City, Osaka, Japan

Tel

0728351010

Email

kawaguchi.ns.reha@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 03 Month 01 Day

Date of IRB

2023 Year 03 Month 29 Day

Anticipated trial start date

2023 Year 03 Month 29 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The FOGQ will be taken twice from Parkinson's disease patients within 2 weeks of study entry. Other questionnaires and measures of physical function will be measured only once within the first 2 weeks of the study. All questionnaires and measures of physical function will be administered outside of rehabilitation.


Management information

Registered date

2023 Year 04 Month 17 Day

Last modified on

2023 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057973


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name